
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cancer immune escape: the role of antigen presentation machinery
Anoop Kallingal, Mateusz Olszewski, Natalia Maciejewska, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 8131-8141
Open Access | Times Cited: 62
Anoop Kallingal, Mateusz Olszewski, Natalia Maciejewska, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 8131-8141
Open Access | Times Cited: 62
Showing 26-50 of 62 citing articles:
Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interaction
Francesco Verona, Sebastiano Di Bella, Roberto Schirano, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Francesco Verona, Sebastiano Di Bella, Roberto Schirano, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Pathophysiology of liver cirrhosis and risk correlation between immune status and the pathogenesis of hepatocellular carcinoma
Manaf Alsudaney, Walid S. Ayoub, Kambiz Kosari, et al.
Hepatoma Research (2025)
Open Access
Manaf Alsudaney, Walid S. Ayoub, Kambiz Kosari, et al.
Hepatoma Research (2025)
Open Access
The search for a TNBC vaccine: the guardian vaccine
Cory Fines, Helen O. McCarthy, Niamh E. Buckley
Cancer Biology & Therapy (2025) Vol. 26, Iss. 1
Open Access
Cory Fines, Helen O. McCarthy, Niamh E. Buckley
Cancer Biology & Therapy (2025) Vol. 26, Iss. 1
Open Access
Unlocking cancer vaccine potential: What are the key factors?
Michael Grant, Lian Ni Lee, Senthil Chinnakannan, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 3
Michael Grant, Lian Ni Lee, Senthil Chinnakannan, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 3
The Importance of HHLA2 in Solid Tumors—A Review of the Literature
Agnieszka Kula, Dominika Koszewska, Anna Kot, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 794-794
Open Access | Times Cited: 3
Agnieszka Kula, Dominika Koszewska, Anna Kot, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 794-794
Open Access | Times Cited: 3
The Roles of H3K9me3 Writers, Readers, and Erasers in Cancer Immunotherapy
Urszula Oleksiewicz, Monika Kuciak, Anna Jaworska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11466-11466
Open Access | Times Cited: 3
Urszula Oleksiewicz, Monika Kuciak, Anna Jaworska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11466-11466
Open Access | Times Cited: 3
A CRISPR activation screen identifies MUC-21 as critical for resistance to NK and T cell-mediated cytotoxicity
Young‐Hee Lee, Hyejin Ahn, Hye-In Sim, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 7
Young‐Hee Lee, Hyejin Ahn, Hye-In Sim, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 7
Cytokine Signaling in Pediatric Kidney Tumor Cell Lines WT-CLS1, WT-3ab and G-401
Elizaveta Fasler‐Kan, Milan Milošević, Sabrina Ruggiero, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2281-2281
Open Access | Times Cited: 2
Elizaveta Fasler‐Kan, Milan Milošević, Sabrina Ruggiero, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2281-2281
Open Access | Times Cited: 2
The prognostic value of immune escape-related genes in lung adenocarcinoma
Jia Hao, Wen Chao Li, Lin Wu
Translational Cancer Research (2024) Vol. 13, Iss. 6, pp. 2647-2661
Open Access | Times Cited: 2
Jia Hao, Wen Chao Li, Lin Wu
Translational Cancer Research (2024) Vol. 13, Iss. 6, pp. 2647-2661
Open Access | Times Cited: 2
Garcinol in gastrointestinal cancer prevention: recent advances and future prospects
Nitika Patwa, Ritu Chauhan, Abhishek Chauhan, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 7
Open Access | Times Cited: 2
Nitika Patwa, Ritu Chauhan, Abhishek Chauhan, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 7
Open Access | Times Cited: 2
Unveiling an anoikis-related risk model and the role of RAD9A in colon cancer
Ting Yang, Yanli Liu, Hailong Guo, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112874-112874
Closed Access | Times Cited: 2
Ting Yang, Yanli Liu, Hailong Guo, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112874-112874
Closed Access | Times Cited: 2
Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer
Ryunosuke Hoshi, Kristyna A. Gorospe, Hagar I. Labouta, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1181-1181
Open Access | Times Cited: 2
Ryunosuke Hoshi, Kristyna A. Gorospe, Hagar I. Labouta, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1181-1181
Open Access | Times Cited: 2
The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives
Sana Ahuja, Sufian Zaheer
Korean Journal of Clinical Oncology (2024) Vol. 20, Iss. 2, pp. 51-73
Closed Access | Times Cited: 2
Sana Ahuja, Sufian Zaheer
Korean Journal of Clinical Oncology (2024) Vol. 20, Iss. 2, pp. 51-73
Closed Access | Times Cited: 2
Strategies to overcome low MHC-I expression in paediatric and adult tumours
Joël Guillaume, Alicia Perzolli, Marianne Boes
Immunotherapy Advances (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 5
Joël Guillaume, Alicia Perzolli, Marianne Boes
Immunotherapy Advances (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 5
Targeting Group 3 Medulloblastoma by the Anti-PRUNE-1 and Anti-LSD1/KDM1A Epigenetic Molecules
Francesca Bibbò, Fatemeh Asadzadeh, Angelo Boccia, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3917-3917
Open Access | Times Cited: 1
Francesca Bibbò, Fatemeh Asadzadeh, Angelo Boccia, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3917-3917
Open Access | Times Cited: 1
Analyzing the Functional Roles and Immunological Features of Chemokines in COAD
Houxi Xu, Yihua Song
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5410-5410
Open Access | Times Cited: 1
Houxi Xu, Yihua Song
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5410-5410
Open Access | Times Cited: 1
GIHP: Graph convolutional neural network based interpretable pan-specific HLA-peptide binding affinity prediction
Lingtao Su, Yan Yan, Bo Ma, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 1
Lingtao Su, Yan Yan, Bo Ma, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 1
Spatial Profiling Reveals Distinct Immune Microenvironment Specific to Premenopausal Triple Negative Breast Cancer
Vidya P. Nimbalkar, V. P. Snijesh, Savitha Rajarajan, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Vidya P. Nimbalkar, V. P. Snijesh, Savitha Rajarajan, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Platinum-based chemotherapy promotes antigen presenting potential in monocytes of patients with high-grade serous ovarian carcinoma
Irina Larionova, Pavel Iamshchikov, Анна Казакова, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Irina Larionova, Pavel Iamshchikov, Анна Казакова, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Tumor Biology Hides Novel Therapeutic Approaches to Diffuse Large B-Cell Lymphoma: A Narrative Review
Romana Masnikosa, Zorica Cvetković, David Pirić
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11384-11384
Open Access | Times Cited: 1
Romana Masnikosa, Zorica Cvetković, David Pirić
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11384-11384
Open Access | Times Cited: 1
Fusobacterium nucleatum promotes PD-L1 expression in cancer cells to evade CD8+ T cell killing in breast cancer
Junlan Guo, Pengcheng Zhu, Jiangli Li, et al.
Human Immunology (2024) Vol. 85, Iss. 6, pp. 111168-111168
Closed Access | Times Cited: 1
Junlan Guo, Pengcheng Zhu, Jiangli Li, et al.
Human Immunology (2024) Vol. 85, Iss. 6, pp. 111168-111168
Closed Access | Times Cited: 1
Single-Sample Networks Reveal Intra-Cytoband Co-Expression Hotspots in Breast Cancer Subtypes
Richard Ponce‐Cusi, Patricio López-Sánchez, Vinicius Maracaja‐Coutinho, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12163-12163
Open Access | Times Cited: 1
Richard Ponce‐Cusi, Patricio López-Sánchez, Vinicius Maracaja‐Coutinho, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12163-12163
Open Access | Times Cited: 1
Vaccine approaches to treat urothelial cancer
Giulia Claire Giudice, Guru P. Sonpavde
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Giulia Claire Giudice, Guru P. Sonpavde
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Canine Breast Carcinomas: Recent Advances in Diagnostic and Treatment Strategies
Pritish Rath, Chitra Jaiswal, D.T. Pal, et al.
Advanced Therapeutics (2024)
Closed Access
Pritish Rath, Chitra Jaiswal, D.T. Pal, et al.
Advanced Therapeutics (2024)
Closed Access
Chemotherapy-mediated lncRNA-induced immune cell plasticity in cancer immunopathogenesis
Jingyuan Lu, Haowei Ma, Qian Wang, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112967-112967
Closed Access
Jingyuan Lu, Haowei Ma, Qian Wang, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112967-112967
Closed Access